NVN Liquidation, Inc. is a medical dermatology company, which engages in the development and commercialization of therapeutic products for skin diseases. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment involves the promotion of treatments for medical dermatology conditions products. The Research and Development Operations segment includes the development of nitric oxide-based technology products. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Durham, NC.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company